Atlas Trials

Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC

Clinical trial NCT00226590 · COMPLETED

Trial details

NCT number
NCT00226590
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2003-04-01
Primary completion
2008-07-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.